Stem cell showdown: Celltex vs. the FDA

January 4, 2013

Celltex’s venture raises some of the most vexing, emotional issues in the business of medicine. Stem cells hold enormous promise, but promise isn’t proof, and anecdotal evidence isn’t science. Small companies often can’t do the research required by the FDA and make money at the same time. (Bloomberg Businessweek)